An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era Z Zhou, LH Sehn, AW Rademaker, LI Gordon, AS LaCasce, ... Blood, The Journal of the American Society of Hematology 123 (6), 837-842, 2014 | 978 | 2014 |
Psychological adjustment and sleep quality in a randomized trial of the effects of a Tibetan yoga intervention in patients with lymphoma L Cohen, C Warneke, RT Fouladi, MA Rodriguez, A Chaoul‐Reich Cancer: Interdisciplinary International Journal of the American Cancer …, 2004 | 698 | 2004 |
High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose … JE Romaguera, L Fayad, MA Rodriguez, KR Broglio, FB Hagemeister, ... J clin oncol 23 (28), 7013-7023, 2005 | 685 | 2005 |
ESHAP--an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study. WS Velasquez, P McLaughlin, S Tucker, FB Hagemeister, F Swan, ... Journal of Clinical Oncology 12 (6), 1169-1176, 1994 | 555 | 1994 |
A mutation in the voltage‐gated sodium channel gene associated with pyrethroid resistance in Latin American Aedes aegypti K Saavedra‐Rodriguez, L Urdaneta‐Marquez, S Rajatileka, M Moulton, ... Insect molecular biology 16 (6), 785-798, 2007 | 442 | 2007 |
Double hit lymphoma: the MD A nderson C ancer C enter clinical experience Y Oki, M Noorani, P Lin, RE Davis, SS Neelapu, L Ma, M Ahmed, ... British journal of haematology 166 (6), 891-901, 2014 | 412 | 2014 |
Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue: an uncontrolled trial G Steinbach, R Ford, G Glober, D Sample, FB Hagemeister, PM Lynch, ... Annals of internal medicine 131 (2), 88-95, 1999 | 325 | 1999 |
Frequency of gastrointestinal involvement and its clinical significance in mantle cell lymphoma JE Romaguera, LJ Medeiros, FB Hagemeister, LE Fayad, MA Rodriguez, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2003 | 318 | 2003 |
Ten‐year follow‐up after intense chemoimmunotherapy with Rituximab‐HyperCVAD alternating with Rituximab‐high dose methotrexate/cytarabine (R‐MA) and without stem cell … JE Romaguera, LE Fayad, L Feng, K Hartig, P Weaver, MA Rodriguez, ... British journal of haematology 150 (2), 200-208, 2010 | 307 | 2010 |
Benefit of consolidative radiation therapy in patients with diffuse large B-cell lymphoma treated with R-CHOP chemotherapy J Phan, A Mazloom, L Jeffrey Medeiros, TG Zreik, C Wogan, F Shihadeh, ... Journal of Clinical Oncology 28 (27), 4170-4176, 2010 | 290 | 2010 |
Unified reference frame dq model of the brushless doubly fed machine J Poza, E Oyarbide, D Roye, M Rodriguez IEE Proceedings-Electric Power Applications 153 (5), 726-734, 2006 | 266 | 2006 |
Improvement of overall and failure-free survival in stage IV follicular lymphoma: 25 years of treatment experience at The University of Texas MD Anderson Cancer Center Q Liu, L Fayad, F Cabanillas, FB Hagemeister, GD Ayers, M Hess, ... J Clin Oncol 24 (10), 1582-9, 2006 | 256 | 2006 |
Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low-grade lymphoma. JR Redman, F Cabanillas, WS Velasquez, P McLaughlin, ... Journal of clinical oncology 10 (5), 790-794, 1992 | 246 | 1992 |
A pilot study of rituximab in patients with recurrent, classic Hodgkin disease A Younes, J Romaguera, F Hagemeister, P McLaughlin, MA Rodriguez, ... Cancer 98 (2), 310-314, 2003 | 212 | 2003 |
A new serologic staging system for large-cell lymphomas based on initial beta 2-microglobulin and lactate dehydrogenase levels. F Swan Jr, WS Velasquez, S Tucker, JR Redman, MA Rodriguez, ... Journal of Clinical Oncology 7 (10), 1518-1527, 1989 | 207 | 1989 |
Liposomal vincristine in relapsed non-Hodgkin's lymphomas: early results of an ongoing phase II trial AH Sarris, F Hagemeister, J Romaguera, MA Rodriguez, P McLaughlin, ... Annals of Oncology 11 (1), 69-72, 2000 | 206 | 2000 |
Long-term follow-up of a prospective study of combined modality therapy for stage I–II indolent non-Hodgkin’s lymphoma JF Seymour, B Pro, LM Fuller, JT Manning, FB Hagemeister, ... Journal of clinical oncology 21 (11), 2115-2122, 2003 | 199 | 2003 |
Vincristine sulfate liposomes injection (Marqibo) in heavily pretreated patients with refractory aggressive non‐Hodgkin lymphoma: report of the pivotal phase 2 study MA Rodriguez, R Pytlik, T Kozak, M Chhanabhai, R Gascoyne, B Lu, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2009 | 191 | 2009 |
Vector control design and experimental evaluation for the brushless doubly fed machine J Poza, E Oyarbide, I Sarasola, M Rodriguez IET Electric Power Applications 3 (4), 247-256, 2009 | 188 | 2009 |
Interleukin-10 levels are often elevated in serum of adults with Hodgkin's disease and are associated with inferior failure-free survival AH Sarris, KO Kliche, P Pethambaram, A Preti, S Tucker, C Jackow, ... Annals of oncology 10 (4), 433-440, 1999 | 187 | 1999 |